Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Harmony Biosciences Holdings (HRMY) Depreciation & Amortization (IS) (2024 - 2025)

Harmony Biosciences Holdings (HRMY) has disclosed Depreciation & Amortization (IS) for 2 consecutive years, with $7.4 million as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (IS) rose 24.53% to $7.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $25.3 million through Dec 2025, up 5.07% year-over-year, with the annual reading at $25.3 million for FY2025, 5.07% up from the prior year.
  • Depreciation & Amortization (IS) hit $7.4 million in Q4 2025 for Harmony Biosciences Holdings, up from $6.0 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (IS) ranged from a high of $7.4 million in Q4 2025 to a low of $6.0 million in Q2 2025.